The warning follows results from postmarketing observational studies that suggested a higher incidence of GBS within 42 days after vaccination, according to a Jan. 7 news release f.
GBS is a rare neurological disorder that causes weakened muscles and, in severe cases, paralysis due to immune system damage to nerve cells.
The FDA has recommended that healthcare professionals monitor patients for signs of GBS following vaccination. Both vaccine manufacturers are following events and effects.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.